Pancreatic Cancer Screening
Over 50,000 new cases of pancreatic cancer are identified in the United States each year. Unfortunately, most patients are diagnosed at later stages of the disease because the symptoms are not always obvious. Patients whose disease is identified in the earliest possible stage have the best chance for positive outcomes. The earlier the stage, the more treatment options that there are available, including surgery.
To date, there is not a universally accepted practice for screening patients for pancreatic cancer. Screening procedures and test are expensive and because pancreatic cancer has a low incidence rate, screening everyone would not be beneficial. However, we recommend routine screening and surveillance for patients that are at a higher risk for developing pancreatic cancer. For more information keep reading below.